The agreement follows the sale of Sekisui's Speciaty Diagnostics Business Unit to BioMedica Diagnostics in December 2016.
ImmBioMed is an innovation, development and marketing consulting company who also distributes in vitro diagnostics to medical laboratories and reagents for industrial and scientific purposes. They will continue to meet all customer needs and the current levels of exceptional service and support, and no interruption in operations is anticipated.
Invitech will continue as the UK distributor for the ADG prefix Coagulation products
Leave A Comment